News | December 26, 2022
Searchlight Pharma to acquire Miravo Healthcare
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Plant is part of the company's CAD $30 million capital investment in the site
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Subscribe To Our Newsletter & Stay Updated
